Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Recruiting
Observational Study
Prostate Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 35 – 70
- Sex
- Male
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- University of Michigan Rogel Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \* Age 35-70 years
* Capable of providing informed consent
* Prognosis of \> 5 years if affected by another cancer
* Patients need one to meet at least one of the following high genetic risk categories:
* Known PCa-related mutations: BRCA 1 and 2, Lynch syndrome, o…
Contacts